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Ithasbeensuggestedthatglucosemetabolismwithinthebrain’sdefaultnetworkisdirectlyassociatedwith—andmayevencause—
theamyloidpathologyofAlzheimer’sdisease(AD).Hereweperformed2-[18F]ﬂuoro-2-deoxy-D-glucose(FDG)and[11C]-labeled
Pittsburgh Compound B (PIB) positron emission tomography (PET) on cognitively normal elderly subjects and on AD patients
and conducted quantitative regional analysis of FDG- and PIB-PET images using an automated region of interest technique. We
conﬁrmedthatrestingglucosemetabolismwithintheposteriorcomponentsofthebrain’sdefaultnetworkishighinnormalelderly
subjects and low in AD patients, which is partially in agreement with the regional pattern of PIB uptake within the default network
of AD patients. However, in several regions outside the default network, glucose metabolism was high in normal elderly subjects
but was not depressed in AD patients, who exhibited signiﬁcantly increased PIB uptakes in these regions. In contrast, the level
of resting glucose metabolism in the default network and in regions outside the default network in normal elderly subjects was
signiﬁcantlycorrelatedwiththelevel ofregionalPIBuptakeinADpatients.Theseresultsarediscussedwithexperimentalevidence
suggesting that beta amyloid production and amyloid precursor protein regulation are dependent on neuronal activity.
1.Introduction
The concept of a default mode network, an interconnected
set of brain regions (the frontal, parietal, posterior cingulate,
lateral, and medial temporal cortices) that is active when the
brain is in a resting state and deactivated during focused
mental tasks, was ﬁrst proposed in 2001 [1] .B u ti tr a p i d l y
became the target of much research on Alzheimer’s disease
(AD),themostcommonformofdementiaandachallenging
global public health problem [2].
The earliest evidence that the default network is dis-
rupted in AD was provided by positron emission tomog-
raphy (PET) studies of resting glucose metabolism using
2-[18F]ﬂuoro-2-deoxy-D-glucose (FDG). AD patients show
a speciﬁc anatomic pattern of reduced glucose metabolism
relative to age-matched healthy controls [3–10]. This pattern
corresponds with the posterior components of the default
network (the posterior cingulate cortex (PCC), inferior
parietal lobule (IP), and lateral temporal cortex (LTC)) [11].
Recently, molecular imaging using [11C]-labeled Pitts-
burgh Compound B (PIB) revealed the amyloid pathology
preferentially accumulates in the default network [2, 9–18].
Therefore, it was suggested that metabolic activity in the
defaultnetwork may be associated with—or even cause—the
pathology of AD [2, 9, 11].
However, there has been no systematic quantitative
investigation of resting glucose metabolism and amyloid
pathology within default network regions as contrasted with
regions outside the default network. Here, we conducted
FDG- and PIB-PET imaging of cognitively normal elderly
subjects and AD patients. We then compared their glu-
cose metabolism and amyloid pathology using quantitative
regional analysis of FDG- and PIB-PET images via an auto-
mated region of interest (ROI) technique. We also compared2 International Journal of Alzheimer’s Disease
Table 1: Demographic information.
Subjects Control AD patients
Number 14 7
Age (yr) 67 ± 47 0 ± 7
Sex (F/M) 9/5 5/2
Handness (right/left) 14/0 7/0
MMSE-K 29 ± 11 8 ± 3
CDR 0 1.6 ± 0.8
Mean ± SD values shown.
AD = Alzheimer disease; MMSE-K = Korean version of Mini Mental State
Examination; CDR = Clinical Dementia Rating.
ApoE4 status of subjects was not available.
FDG- and PIB-PET patterns in the default network regions
with those in regions outside the default network.
2.MaterialsandMethods
2.1. Subjects. Twenty-one subjects were included in this
study.Writteninformedconsentwasobtainedafteradetailed
explanation of the procedure, which was reviewed by the
InstituteReviewBoardof theGachonUniversity ofMedicine
and Science, Incheon, South Korea. None of the subjects
had a previous history of other neurological, medical, or
psychiatric conditions. All subjects received neurological,
psychiatric, and neuropsychological evaluations, PIB- and
FDG-PET scans and a magnetic resonance imaging (MRI)
scan in addition to routine laboratory tests. Brain MRI scans
were used to conﬁrm that territorial cerebral infarctions,
brain tumors, and other structural lesions were absent. AD
patientswereidentiﬁedusingthestandarddiagnosticcriteria
of memory impairment, impairment in at least one other
cognitive domain, gradual onset and progressive decline,
and impaired occupational or social functioning or both
[19]. Control subjects were cognitively normal for age and
did not meet the criteria for mild cognitive impairment or
AD. Seven subjects (ﬁve females and two males) met the
diagnostic criteria for dementia of the Alzheimer type, and
14 subjects (nine females and ﬁve males) were cognitively
normal (controls). The mean age and standard deviation
(SD) was 70 ± 7y e a r sf o rA Ds u b j e c t sa n d6 7± 4y e a r sf o r
control subjects. The age diﬀerence between the two groups
was not statistically signiﬁcant (P>. 05). The results of mini
mental state examinations, a measure of global cognitive
function, were (mean ± SD) 18 ± 3 for AD subjects and 29
± 1 for the controls (P<. 001). Clinical dementia ratings
were zero for control subjects and 1.6 ± 0.8 (mean ± SD)
for AD patients. Demographic information is summarized
in Table 1.
2.2. PET Imaging. [18F]FDG was prepared at a very high
speciﬁc activity as described previously [20]. For FDG-
PET, PET scans of 20min were acquired 40min after an
intravenous injection of 4.8MBq/kg of FDG. Participants
had fasted for at least 6h before the FDG-PET scan. To
minimize external stimuli during the radiotracer uptake
period, participants remained in a dimly lit room with their
eyes closed. The PET imaging probe for visualizing amyloid
plaques (PIB) was prepared according to published protocols
[21]. For PIB-PET, 20min PET scans were acquired 40min
after an intravenous injection of 9.6MBq/kg of PIB on a
diﬀerentdaytothatonwhichFDG-PETscanswereobtained.
Our scanning protocol (i.e., 20min static scan 40min after
injection for both FDG and PIB) has been previously
validated by Lopresti et al. [22] for PIB and Mosconi et al.
[23] for FDG, respectively. All brain scans were performed
using a Biograph 6 Hi-Rez scanner (Siemens-CTI, Knoxville,
TN) in three-dimensional (3D) acquisition mode after
administration of an intravenous injection of a bolus of PET
tracer. The Biograph 6 is a commercial PET/CT (computed
tomography) human whole-body scanner with an electrical
ﬁeld of view 585mm in width and 162mm in axial length.
The Biograph 6 uses Hi-Rez PET scan modules to achieve
a very ﬁne spatial resolution of 4-5mm, and performs
attenuation-correction transmission measurements of the
emission scans using X-ray CT. An X-ray source rotation
speed of 0.8s at 130kVp with a tube current of 240mA
was used to generate the X-ray CT scan. All PET scans
were decay-corrected and reconstructed using an iterative
reconstruction algorithm based on ordered-subset expec-
tation maximization with scatter correction and measured
attenuation correction. OSEM images underwent 5.5mm
full-width-at-half-maximum Gaussian postsmoothing.
2.3. PET Data Quantiﬁcation. [11C]PIB quantiﬁcation was
performed using a relative standard uptake value (SUVR;
evaluated at equilibrium and normalized for the cerebellum
gray matter) of 40–60min. This analytic method has been
validated previously [22]. Of several diﬀerent PIB quantiﬁ-
cation methods, the late-scan reference method has shown
a large size eﬀect [22]. [18F]FDG quantiﬁcation was done
usinganSUVRnormalizedforcerebellumgraymatterof40–
60min. This quantiﬁcation protocol has been validated pre-
viously [23]. The gray matter of the cerebellum was used as
the reference region for both PIB and FDG analyses because
the cerebellum is minimally aﬀected by reductions in glucose
metabolism [3, 6] and amyloid pathology [24, 25]i nA D .
2.4. MRI. Anatomical brain MRI scans were acquired using
a 1.5 T Siemens Avanto system (Erlangen, Germany) with a
3D T1-MPRAGE sequence as follows: TR = 1160ms, TE =
4.24ms, TI = 600ms, FA = 15◦,B W= 180Hz/Px, matrix size
= 512 × 512, number of slices = 192, slice thickness = 1mm,
FOV = 25.6 ×25.6cm 2, and NEX = 1.
2.5. ROIs. All image processing and data analyses were
performed blind to clinical diagnoses. Coregistering of PIB-
and FDG-PET images with the corresponding MRI images
was performed using statistical parameter mapping software
(SPM5; Wellcome Department of Cognitive Neurology,
Institute of Neurology, London, UK), which was imple-
mented using Matlab 6.5 (MathWorks Inc., Sherborn, MA).
The coregistered FDG- and PIB-PET images were trans-
f e r r e dt oaS u nS p a r cw o r k s t a t i o n( S u nM i c r o s y s t e m s ,
Mountain View, CA) for automated ROI analysis. An MRI-





























tomography (PET) imaging of FDG in a normal 65-year-old man (left upper panel) and a 60-year-old woman with AD (right upper panel).
(b) PET imaging of PIB in the same normal subject (left lower panel) and the same AD patient (right lower panel).
technique was used to sample each individual’s FDG and
PIB images (see [14] for details). Brieﬂy, the template ROI
was ﬁrst developed using seven MRI scans and was then
transferred to a coregistered MNI PET template. All PET
scans were normalized to the PET template using high-
order polynomial transformation [26]. Having saved the
spatial normalization parameters, an inverse transformation
was applied to morph the ROIs back to the original FDG-
PET. The standard FDG-ROIs were then transferred to the
PIB scan in real space through the coregistration. ROI
positioning was veriﬁed on the MRI, but no positioning
adjustments were made in this project. To maximize gray
matter sampling, a probabilistic gray matter template image
derived from the SPM software was applied to the template
R O I( s e e[ 14]). Fifteen MRI and FDG-PET-validated auto-
mated ROIs were studied: the IP, PCC, LTC, putamen (PU),
visual cortex (VC), occipital cortex (OC), hippocampus
(HIP), middle frontal gyrus (MFG), superior temporal gyrus
(STG), thalamus (TH), amygdala (AMY), medial temporal
cortex (MTC), prefrontal cortex (PFC), orbitofrontal cortex
(OFC), and cerebellum.
2.6. Statistical Analysis. Independent Student’s t-tests were
used to assess the signiﬁcance of diﬀerences in PIB and FDG
means between AD subjects and controls. We performed
ANOVA to compare diﬀerences in radiotracer uptake within
diﬀerent brain regions between AD subjects and controls,
which was followed by Tukey’s post hoc test. Pearson’s
correlations were used to assess bivariate relationships (SPSS
Version 12, SPSS Inc., Chicago, IL).
3. Results
The upper left panel of Figure 1 shows an FDG-PET image
of a representative normal elderly subject. The posterior
components of the default network (the posterior cingulate
cortex and the precuneus) exhibited higher resting glucose
metabolism than most other brain regions. However, it
should be noted that the high glucose metabolism was
not restricted to the default network because the primary
visual cortex also exhibited high resting glucose metabolism
(Figure 1, upper left panel). The FDG-PET image from
a representative AD patient (Figure 1,u p p e rr i g h tp a n e l )
shows hypometabolism in the posterior cingulated cortex
and the precuneus. In contrast, the visual cortex of the AD
patient did not show hypometabolism (Figure 1,u p p e rr i g h t
panel). On the other hand, a PIB-PET image from the same
AD patient showed increased PIB uptake not only in parts of
the default network such as the posterior cingulated cortex
and the precuneus, but also in regions outside the default
network(e.g.,thevisualcortex)(Figure 1,lo w errightpanel).
These observations show that regions outside the default
network may exhibit high resting glucose metabolism and
amyloid pathology.4 International Journal of Alzheimer’s Disease
Table 2: 2-[18F]ﬂuoro-2-deoxy-D-glucose (FDG) and [11C]-labeled Pittsburgh Compound B (PIB) uptakes in the default network regions
and regions outside the default network in Alzheimer’s disease (AD) and control subjects.
Subject Control AD
Radiotracer FDG PIB FDG PIB
Default network
MFG 1.20 ± 0.074 1.09 ± 0.104 0.96 ± 0.137†† 1.92 ± 0.229∗∗
MTC 0.81 ± 0.041 1.06 ± 0.084 0.74 ± 0.069† 1.16 ± 0.126∗
LTC 0.98 ± 0.033 1.11 ± 0.099 0.83 ± 0.120† 1.63 ± 0.207∗∗
IP 1.11 ± 0.045 1.09 ± 0.078 0.90 ± 0.123†† 1.84 ± 0.164∗∗
PCC 1.21 ± 0.039 1.10 ± 0.090 1.00 ± 0.158† 2.11 ± 0.198∗∗
PFC 1.11 ± 0.042 1.08 ± 0.152 0.93 ± 0.115† 1.88 ± 0.183∗∗
OFC 1.10 ± 0.043 1.02 ± 0.163 0.92 ± 0.123† 1.74 ± 0.161∗∗
HIP 0.82 ± 0.052 1.03 ± 0.082 0.76 ± 0.109 1.03 ± 0.116
Nondefault network
PU 1.21 ± 0.080 1.21 ± 0.194 1.16 ± 0.118 2.05 ± 0.350∗∗
STG 1.04 ± 0.042 1.13 ± 0.090 0.89 ± 0.135† 1.57 ± 0.216∗
TH 1.19 ± 0.090 1.29 ± 0.109 1.08 ± 0.115† 1.44 ± 0.250
VC 1.24 ± 0.050 1.05 ± 0.117 1.28 ± 0.131 1.46 ± 0.250∗∗
OC 1.13 ± 0.048 1.09 ± 0.098 1.12 ± 0.119 1.57 ± 0.220∗
AMY 0.72 ± 0.050 1.00 ± 0.096 0.69 ± 0.062 1.06 ± 0.109
Mean ± SD.
†P <. 05 versus FDG control, two-tailed t test.
††P<. 001 versus FDG control.
∗P<. 05 versus PIB control, two-tailed t test.
∗∗P<. 001 versus. PIB control.
MFG: middle frontal gyrus, MTC: medial temporal cortex, LTC: lateral temporal cortex, IP: inferior parietal lobe, PCC: posterior cingulate cortex, PFC:
prefrontal cortex, OFC: orbitofrontal cortex, HIP: hippocampus, PU: putamen, STG: superior temporal gyrus, TH: thalamus, VC: visual cortex, OC: occipital
cortex, AMY: amygdala.
To compare resting glucose metabolism and PIB uptake
within the default network regions with those in regions
outside the default network, we performed quantitative
regional analysis of FDG- and PIB-PET images using an
automated ROI technique.
3.1.QuantitativeRegionalAnalysisofFDG-PETImages. FDG
uptakes by the default network regions and regions outside
the default network in AD and control subjects are shown
in Table 2. Comparison between the AD and control groups
revealed that (1) in the default network, the resting glucose
metabolism of AD patients was signiﬁcantly less than that
of the controls in the MFG, MTC, LTC, IP, PCC, PFC, and
OFC; (2) in the default network, resting glucose metabolism
was statistically weakly reduced in the HIP of AD patients
comparedwithcontrols(ADpatients,0.76 ± 0.109; controls,
0.82 ± 0.052; P = .076); (3) in the nondefault network, the
resting glucose metabolism of AD patients was signiﬁcantly
less than that of the controls in the STG and TH; (4) in
the nondefault network, resting glucose metabolism did not
diﬀer signiﬁcantly between AD patients and controls in the
P U ,V C ,O C ,a n dA M Y .
Figure 2 shows the mean and SE of SUVRs for FDG-PET
for the default and nondefault networks of normal elderly
subjects and AD patients. In normal elderly subjects, the
regions of the brain can be classed into two groups based on
restingglucosemetabolism:regionswithhighrestingglucose
metabolism (the MFG, LTC, IP, PCC, PFC, and OFC in the
default network and the PU, STG, TH, VC, and OC in the
nondefault network), and regions with low resting glucose
metabolism (the MTC and the HIP in the default network
and the AMY in the nondefault network).
3.2. Quantitative Regional Analysis of PIB-PET Images. PIB
uptakes for various brain regions of the AD and control
groups are shown in Table 2. Comparison of the AD and
control groups revealed that (1) in the default network, PIB
uptake of AD patients was signiﬁcantly greater than that of
the controls in the MFG, MTC, LTC, IP, PCC, PFC, and
OFC; (2) in the default network, PIB uptake did not diﬀer
signiﬁcantly between AD patients and controls in the HIP;
(3)inthenondefaultnetwork,PIBuptakeofADpatientswas
signiﬁcantly greater than that of the controls in the PU, STG,
VC, and OC; (4) in the nondefault network, PIB uptake did
not diﬀer signiﬁcantly between AD patients and controls in
the TH and AMY.
Figure 3 shows the mean and SE of SUVRs for PIB-PET
for the default and nondefault networks of normal elderly
subjects and AD patients. In AD patients, the regions of the
brain can be classed into two groups based on PIB uptake:
regions with high PIB uptake (the MFG, LTC, IP, PCC, PFC,
and OFC in the default network and the PU, STG, TH, VC,
andOCinthenondefaultnetwork)andregionswithlowPIB
uptake (the MTC and HIP in the default network and the
AMY in the nondefault network).
3.3. Comparison of PIB and FDG-PET Regional Patterns.
Table 3 shows patterns of resting glucose metabolism
and amyloid deposition for the default and nondefault
networks. In the default network of AD patients, the patternInternational Journal of Alzheimer’s Disease 5


































Region of interest (ROIs)
Figure 2: Regional FDG uptakes in normal control subjects and Alzheimer’s disease (AD) patients. Mean and SE of relative standardized
uptake values (SUVRs) for FDG-PET in various brain regions in normal (black bars) and AD subjects (gray bars). MFG: middle frontal
gyrus, MTC: medial temporal cortex, LTC: lateral temporal cortex, IP: inferior parietal lobe, PCC: posterior cingulate cortex, PFC: prefrontal
cortex, OFC: orbitofrontal cortex, HIP: hippocampus, PU: putamen, STG: superior temporal gyrus, TH: thalamus, VC: visual cortex, OC:
occipital cortex, AMY: amygdala. ∗P<. 05, two-tailed t test.



































Region of interest (ROIs)
Figure 3: Regional PIB uptakes in normal control subjects and Alzheimer’s disease (AD) patients. Mean and SE of SUVRs for PIB-PET
in various brain regions in normal (black bars) and AD subjects (gray bars). MFG: middle frontal gyrus, MTC: medial temporal cortex,
LTC: lateral temporal cortex, IP: inferior parietal lobe, PCC: posterior cingulate cortex, PFC: prefrontal cortex, OFC: orbitofrontal cortex,
HIP: hippocampus, PU: putamen, STG: superior temporal gyrus, TH: thalamus, VC: visual cortex, OC: occipital cortex, AMY: amygdala.
∗P<. 05, two-tailed t test.6 International Journal of Alzheimer’s Disease
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Regional resting glucose metabolism level in normal elderly
Figure 4: The relationship between resting glucose metabolism levels and PIB uptakes. The correlation between regional resting glucose
metabolism in normal elderly subjects and regional PIB uptake in Alzheimer’s disease (AD) patients from various diﬀerent brain areas
is highly signiﬁcant (0.788, P = .001). This correlation demonstrates that brain regions with high resting glucose metabolism in normal
elderly subjects have high PIB uptakes in AD patients and that brain regions with low resting glucose metabolism have low PIB uptakes in
AD patients. Most importantly, it should be noted that resting glucose metabolism level and PIB uptake are correlated not only in the brain’s
default network regions but also in brain regions outside the default network.
of resting glucose metabolism was associated with the
pattern of hypometabolism and the pattern of PIB uptake.
This result is consistent with previous reports. However,
nondefault network regions such as the PU and VC showed
no hypometabolism but had high PIB uptake. Therefore, the
pattern of hypometabolism does not correspond with that
of PIB uptake in AD patients.
In contrast, the pattern of resting glucose metabolism
corresponded with the pattern of PIB uptake in nonde-
fault network regions. Therefore, we conducted correlation
analysis between regional resting FDG SUVR values in
normal elderly subjects and regional PIB SUVR values in
AD patients, and observed a highly signiﬁcant correlation
(Figure 4) (0.788, P = .001). This result suggests that brain
regions with high resting glucose metabolism may accelerate
the formation of amyloid pathology associated with AD.
4. Discussion
To our knowledge, this is the ﬁrst quantitative study on
the relationship between resting glucose metabolism and
a m y l o i dp a t h o l o g yi nd e f a u l tn e t w o r kr e g i o n sa sw e l la si n
regions outside the default network. In addition to conﬁrm-
ing the well-known regional associations between glucose
metabolism and PIB uptake in the brain’s default network,
this study investigated whether brain regions outside the
default network exhibit the same relationships. Surprisingly,
we found that whereas resting glucose metabolism level was
associated with the pattern of PIB uptake in the nondefault
network, the pattern of glucose hypometabolism did not
match the amyloid pathology pattern in the nondefault
network. Taken together, we found a statistically signiﬁcant
correlation between the level of resting glucose metabolism
in normal elderly subjects and PIB uptake in AD patients in
the default and nondefault network regions.
That the PU and VC exhibited high PIB uptake but
insigniﬁcant glucose hypometabolism, suggests that amyloid
plaque accumulation per se does not result in glucose
hypometabolism in AD. For the same reason, it is also
inferred that glucose hypometabolism per se does not result
in amyloid plaque accumulation (see Figures 2 and 3). If low
glucose metabolism is not associated with amyloid plaque
accumulation, what is the association between high glucose
metabolism and amyloid plaque accumulation? It has been
suggested that high baseline levels of glucose metabolism
in the default network may be conducive to the formation
of amyloid pathology associated with AD [2, 9, 11]. Our
results show that this proposal may be generalized as follows.
Regardless of whether a brain region belongs to the default
network or not, the resting glucose metabolism level within
a region in healthy subjects is associated with the level
of amyloid pathology in that region in AD patients. The
statistically signiﬁcant correlation between the regional
resting glucose metabolism level in normal elderly subjects
and regional PIB uptake values in AD patients in both
default network regions and nondefault network regions
supports this generalization (see Figure 4).
Histological studies have demonstrated that amyloid
plaquedepositionisprominentintheneocorticalregionsbut
is not especially prominent in the MTC and the HIP [27].
To date, all PIB-PET imaging studies have consistently con-
ﬁrmed this histological feature of amyloid plaque deposition
in that PIB uptake is high in the neocortical regions but is
minimal in the HIP and the MTC [11, 13, 14, 16]. If so, what
kind of mechanism is responsible for this unique feature of
the regional pattern of amyloid plaque deposition?International Journal of Alzheimer’s Disease 7
Table 3: Comparison of the patterns of resting glucose metabolism, glucose hypometabolism, and amyloid deposition in the default and
nondefault networks.
Region Resting metabolism level Hypometabolism Amyloid accumulation
Default network
MFG + + +
MTC −− /+ −/+
LTC + + +
IP + + +
PCC + + +
PFC + + +
OFC + + +
HIP −− /+ −
Nondefault network
PU + − +
STG + + +
TH + + −/+
VC + − +
OC + − +
AMY −− −
−,l o we ﬀect; +, high eﬀect; −/+, minimal eﬀect.
MFG: middle frontal gyrus, MTC: medial temporal cortex, LTC: lateral temporal cortex, IP: inferior parietal lobe, PCC: posterior cingulate cortex, PFC:
prefrontal cortex, OFC: orbitofrontal cortex, HIP: hippocampus, PU: putamen, STG: superior temporal gyrus, TH: thalamus, VC: visual cortex, OC: occipital
cortex, AMY: amygdala.
Several lines of evidence suggest that beta amyloid
production and amyloid precursor protein regulation are
dependent on neuronal activity [28–32]. Beta amyloid
peptide (Aβ) is secreted from healthy neurons in response
to neuronal activity, and Aβ, in turn, downregulates exci-
tatory synaptic transmission [29]. This negative feedback
loop, in which neuronal activity promotes Aβ production,
which decreases synaptic activity, represents a homeostatic
mechanismforcontrollingthelevelofneuronalactivity[30].
It was suggested that the regulatory feedback loop between
neuronal activity and Aβ production is impaired in AD
patients, resulting in unchecked accumulation of Aβ and
neurotoxicity [29].
The energy metabolism of the adult mammalian brain
is almost entirely dependent on glucose and the majority
of the glucose taken up by the brain is used for mainte-
nance of membrane potentials and electrical activity [33].
Because neuronal activity is closely associated with energy
metabolism, measurements of cerebral glucose metabolism
can be used to gain insights into the neuronal activity of
all of the neuroanatomically deﬁned regions of the brain
[34, 35]. Sensors of glucose metabolism are necessary to
make adaptive changes to variations in glucose metabolism.
It has been proposed that the adenosine monophosphate-
activated protein kinase (AMPK) signaling complex is a
glucose metabolism sensor and that it may be involved in
neuroprotectiveprocesses(see[36]forareview).Inaddition,
a recent animal study provided evidence that AMPK is a key
regulatorofAD-relatedpathology[37].Takentogether,given
the regulatory feedback loop between neuronal activity and
Aβproduction[29,30],itispossiblethathighrestingglucose
metabolism, as reﬂected by FDG-PET, may accelerate the
formation of amyloid pathology in AD. If this is the case, the
low level of resting glucose metabolism in the HIP and the
MTC (see Figure 2) relative to that in the neocortical regions
mayexplainwhyweobservedminimalPIBuptakeintheHIP
and the MTC of AD patients (see Figure 3).
On the other hand, recently the relationship between
gray matter atrophy and amyloid deposition in AD was
investigated using volumetric magnetic resonance and PIB-
PET [38]. This study found that signiﬁcant correlations
between atrophy and increased PIB uptake were found
in the hippocampal (r =− 0.54) and amygdalar ROIs
(r =− 0.40) but not in the frontal, temporal, posterior
cingulate/retrosplenial, insular, and caudate ROIs (r between
0.04 and 0.25). Therefore, these results suggest that the
hippocampus and amygdala might be highly susceptible to
amyloid toxicity, whereas neocortical areas might be more
resilient. Based on this suggestion, an alternative explanation
for our present ﬁndings is that diﬀerent brain areas may be
diﬀerentially susceptible for amyloid toxicity.
Inconclusion,withinthedefaultnetwork,restingglucose
metabolism level in healthy subjects, glucose hypome-
tabolism in AD patients, and amyloid pathology in AD
patients are coincident (see Table 3). Therefore, it is diﬃcult
to determine whether high resting glucose metabolism or
decreased metabolism is associated with amyloid pathol-
ogy. Our quantitative regional analysis demonstrates that
high resting glucose metabolic activity, rather than glucose
hypometabolism, is associated with the pattern of beta
amyloid plaque (or PIB uptake) in AD (see Table 3 and
Figure 4). However, it should be also noted that the patient
population in the current group is utterly small. Therefore,
the results based on this small sample are very preliminary
andonlygiveaﬁrsthintthathighrestingmetabolismmaybe
associated with later amyloid deposition. These results need
to be longitudinally conﬁrmed in larger samples before they
can be transferred to the general population.8 International Journal of Alzheimer’s Disease
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